Please Note: Blog posts are not selected, edited or screened by Seeking Alpha editors.

Small healthcare with a possible pipeline in the making ! PPHM SA flash !

9:06 AM Peregrine Pharmaceuticals (PPHM) says study results show combining its bavituximab antibody with chemotherapy treatment improved the overall tumor response rate in lung cancer patients, 39% vs. a 26% response in patients who only received the chemotherapy drugs. PPHM +28% premarket